Today on DrugResearcher.com   GSK allies with OncoMed to beat cancer stem cells Roche targets Ventana's board to force takeover Carl Zeiss licenses 'record-breaking' fluorescence technology Two early-phase CROs merge Eisai continues biologics push with $3.9bn MGI Pharma buy

Related Industry News   Puerto Rico pursuing biologic bucks Transport wins for elecrokinetic drug delivery William Ransom & Son recall false contaminated products Millipore partners Rohm and Haas to develop new chromatography media

Breaking News on Drug Discovery
Daily  Tuesday 11 December 2007		Forward to a colleague

	Sponsored Link Excellent value for money for routine moisture determination The TitraLab 580 and 585 Volumetric Karl Fischer Workstations are ideal for fast and accurate moisture determination whether you are working with solids or liquids. Operation is simple thanks to pre-programmed functions and dedicated buttons for solvent addition and cell... Click Here Access Full Stories GSK allies with OncoMed to beat cancer stem cells GlaxoSmithKline (GSK) and OncoMed are teaming up to develop novel antibody therapies that target the cancer stem cells believed to play a key role in forming cancers... Read Roche targets Ventana's board to force takeover The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Carl Zeiss licenses 'record-breaking' fluorescence technology Microscopy expert-Carl Zeiss has licensed a new fluorescence microscopy technique that enables scientists to determine the precise intracellular location of proteins of interest... Read Two early-phase CROs merge Two US players in the early-phase contract research organisation (CRO) space have announced their intentions to merge... Read Eisai continues biologics push with $3.9bn MGI Pharma buy Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline... Read
	All News Headlines for: December | November | October
	Product Presentation ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here
	Related Industry News Puerto Rico pursuing biologic bucks Puerto Rico is making a concerted effort to attract biologic investment dollars onto the island as it falls foul of a retreat from pharma firms seeking solid dose manufacturing... Read Transport wins for elecrokinetic drug delivery Transport Pharmaceuticals has been named the 2007 North American Technology Innovation of the Year Award winner in electrokinesis-enabled drug delivery... Read William Ransom & Son recall false contaminated products UK-based William Ransom & Son has been advised to voluntarily recall certain products following a false contamination scare at its Witham, Essex, facility... Read Millipore partners Rohm and Haas to develop new chromatography media Separations expert Millipore is collaborating with Rohm and Haas Company to develop new high-performance chromatography products for use in biopharmaceutical manufacturing... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Previous Headlines ACD/Labs takes the stress out of NMR spectral analysis ACD/Labs has unveiled a new programme designed to help synthetic chemists reduce the amount of time required to spend on NMR (nuclear magnetic resonance) data analysis... Read Galapagos branches out with new GSK deal GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos in a new development partnership, in a deal worth up to €218m for the Belgian biotech... Read Microfluidics promises a bright future for cell-based assays UK researchers have published results that show that microfluidic devices can provide robust quantitative pharmacological information from low numbers of single cells... Read BMS reveals plans to trim the fat Bristol-Myers Squibb (BMS) has finally detailed its plans to trim the fat and save cash, months after first revealing that big changes would be on the cards... Read Drugs moving into the clinic: 38 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com